TNF-binding protein-1 in the treatment of psoriasis

摘要

The treatment of psoriasis by administering an anti-TNF-alpha agent is here described. Such a treatment is performed according to specific doses, regimens and route of administration. In particular the anti-TNF-alpha agent is recombinant human TNF-binding protein-1 (r-hTBP-1) and the psoriasis is defined as moderate to severe or associated with psoriatic arthritis.